In this line, DPT expression has been shown to be upregulated in the liver of patients with nonalcoholic steatohepatitis (NASH) and fibrosis with its expression decreasing after gastric bypass in parallel with the reduction of the fibrosis stage [10]. Here, DPT is linked to metabolic dysfunction-associated steatohepatitis.